• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤 T 细胞独立于肿瘤特异性细胞毒性 T 细胞控制小鼠自发性癌。

iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.

机构信息

Cellular Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, Istituto Scientifico San Raffaele, Milan, Italy.

出版信息

PLoS One. 2010 Jan 13;5(1):e8646. doi: 10.1371/journal.pone.0008646.

DOI:10.1371/journal.pone.0008646
PMID:20072624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2800182/
Abstract

BACKGROUND

CD1d-restricted invariant NKT (iNKT) cells are a subset of T lymphocytes endowed with innate effector functions that aid in the establishment of adaptive T and B cell immune responses. iNKT cells have been shown to play a spontaneous protective role against experimental tumors. Yet, the interplay between iNKT and tumor-specific T cells in cancer immune surveillance/editing has never been addressed. The transgenic adenocarcinoma of the mouse prostate (TRAMP) is a realistic model of spontaneous oncogenesis, in which the tumor-specific cytotoxic T cell (CTL) response undergoes full tolerance upon disease progression.

PRINCIPAL FINDINGS

We report here that lack of iNKT cells in TRAMP mice resulted in the appearance of more precocious and aggressive tumors that significantly reduced animal survival. TRAMP mice bearing or lacking iNKT cells responded similarly to a tumor-specific vaccination and developed tolerance to a tumor-associated antigen at comparable rate.

CONCLUSIONS

Hence, our data argue for a critical role of iNKT cells in the immune surveillance of carcinoma that is independent of tumor-specific CTL.

摘要

背景

CD1d 限制性不变自然杀伤 T(iNKT)细胞是一群具有先天效应功能的 T 淋巴细胞亚群,有助于建立适应性 T 和 B 细胞免疫反应。iNKT 细胞已被证明在实验性肿瘤中发挥自发的保护作用。然而,iNKT 细胞与肿瘤特异性 T 细胞在癌症免疫监视/编辑中的相互作用尚未得到解决。小鼠前列腺腺癌(TRAMP)是自发发生肿瘤的现实模型,其中肿瘤特异性细胞毒性 T 细胞(CTL)反应在疾病进展时会完全耐受。

主要发现

我们在这里报告,TRAMP 小鼠中缺乏 iNKT 细胞会导致更早熟和侵袭性肿瘤的出现,这显著降低了动物的存活率。携带或缺乏 iNKT 细胞的 TRAMP 小鼠对肿瘤特异性疫苗有类似的反应,并以相似的速度对肿瘤相关抗原产生耐受。

结论

因此,我们的数据表明,iNKT 细胞在对癌的免疫监视中起着关键作用,而与肿瘤特异性 CTL 无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/ac2ddf911b12/pone.0008646.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/ab4b7bb0a904/pone.0008646.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/123ef53b8cb5/pone.0008646.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/c458cbce4381/pone.0008646.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/f0e69cdcc03e/pone.0008646.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/ac2ddf911b12/pone.0008646.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/ab4b7bb0a904/pone.0008646.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/123ef53b8cb5/pone.0008646.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/c458cbce4381/pone.0008646.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/f0e69cdcc03e/pone.0008646.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ed/2800182/ac2ddf911b12/pone.0008646.g005.jpg

相似文献

1
iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.自然杀伤 T 细胞独立于肿瘤特异性细胞毒性 T 细胞控制小鼠自发性癌。
PLoS One. 2010 Jan 13;5(1):e8646. doi: 10.1371/journal.pone.0008646.
2
Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.CD1d+TRAMP 前列腺肿瘤细胞通过缺陷 NKT 细胞激活是由白细胞介素-12 与 α-半乳糖神经酰胺纠正的。
PLoS One. 2010 Jun 25;5(6):e11311. doi: 10.1371/journal.pone.0011311.
3
Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.部分规避针对癌基因特异性前列腺癌免疫疗法的外周耐受。
Prostate. 2008 May 15;68(7):715-27. doi: 10.1002/pros.20689.
4
Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.不变自然杀伤 T 细胞通过直接识别 T 细胞上的 CD1d 促进细胞毒性 T 细胞激活。
Exp Mol Med. 2019 Oct 25;51(10):1-9. doi: 10.1038/s12276-019-0329-9.
5
CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.细菌超抗原非依赖 CD1d 激活小鼠和人 iNKT 细胞。
Immunol Cell Biol. 2012 Aug;90(7):699-709. doi: 10.1038/icb.2011.90. Epub 2011 Nov 1.
6
Invariant NKT cells: regulation and function during viral infection.不变自然杀伤 T 细胞:病毒感染期间的调节和功能。
PLoS Pathog. 2012;8(8):e1002838. doi: 10.1371/journal.ppat.1002838. Epub 2012 Aug 16.
7
CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells.CD1d非限制性自然杀伤T细胞具有一种远优于诱导性自然杀伤T细胞的混合功能。
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12841-6. doi: 10.1073/pnas.1323405111. Epub 2014 Aug 20.
8
Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.外周T细胞耐受性在前列腺癌自发发展的早期出现,并且可以通过树突状细胞免疫来挽救。
Eur J Immunol. 2005 Jan;35(1):66-75. doi: 10.1002/eji.200425531.
9
Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.CD1d 限制性不变自然杀伤 T 细胞在刺激肝内 CD8 T 细胞对肝脏抗原的应答中起关键作用。
Gastroenterology. 2008 Jun;134(7):2132-43. doi: 10.1053/j.gastro.2008.02.037. Epub 2008 Feb 21.
10
Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells.人源 CD1d 敲入小鼠模型显示人源 CD1d 限制性恒定自然杀伤 T 细胞具有强大的抗肿瘤潜力。
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2963-8. doi: 10.1073/pnas.1300200110. Epub 2013 Feb 4.

引用本文的文献

1
T Cell Receptor-Engaging Monoclonal Antibodies Mobilize the Anti-Tumor Functions of Invariant Natural Killer T Cells.T 细胞受体结合型单克隆抗体调动固有自然杀伤 T 细胞的抗肿瘤功能。
Crit Rev Oncog. 2024;29(1):69-81. doi: 10.1615/CritRevOncog.2023049947.
2
The causality between CD8NKT cells and CD16CD56 on NK cells with hepatocellular carcinoma: a Mendelian randomization study.CD8 NKT细胞与自然杀伤细胞上的CD16 CD56在肝细胞癌中的因果关系:一项孟德尔随机化研究。
Infect Agent Cancer. 2024 Jan 20;19(1):3. doi: 10.1186/s13027-024-00565-8.
3
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors.

本文引用的文献

1
Dicer-dependent microRNA pathway controls invariant NKT cell development.依赖Dicer的微小RNA途径控制恒定自然杀伤T细胞的发育。
J Immunol. 2009 Aug 15;183(4):2506-12. doi: 10.4049/jimmunol.0901361. Epub 2009 Jul 22.
2
Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.Vα24不变自然杀伤T细胞通过杀伤肿瘤相关巨噬细胞介导抗肿瘤活性。
J Clin Invest. 2009 Jun;119(6):1524-36. doi: 10.1172/JCI37869.
3
Type I natural killer T cells suppress tumors caused by p53 loss in mice.I型自然杀伤T细胞可抑制小鼠中因p53缺失导致的肿瘤。
前列腺癌中的肿瘤固有免疫微环境:可溶性因子和细胞效应器概述
Explor Target Antitumor Ther. 2022;3(5):694-718. doi: 10.37349/etat.2022.00108. Epub 2022 Oct 31.
4
Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment.采用工程化iNKT细胞进行过继性免疫疗法以靶向癌细胞和抑制性微环境。
Front Med (Lausanne). 2022 May 9;9:897750. doi: 10.3389/fmed.2022.897750. eCollection 2022.
5
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.不变自然杀伤 T 细胞增强的 GM-CSF 分泌肿瘤疫苗在晚期前列腺癌模型中有效。
Cancer Immunol Immunother. 2022 Dec;71(12):2943-2955. doi: 10.1007/s00262-022-03210-8. Epub 2022 May 6.
6
Targeting Sphingolipids for Cancer Therapy.靶向鞘脂用于癌症治疗。
Front Oncol. 2021 Oct 19;11:745092. doi: 10.3389/fonc.2021.745092. eCollection 2021.
7
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead.NKT细胞免疫疗法的现状与未来挑战
Cancers (Basel). 2021 Oct 15;13(20):5174. doi: 10.3390/cancers13205174.
8
Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin-granzyme pathway.人肠道和循环中的不变自然杀伤 T 细胞通过穿孔素-颗粒酶途径对结直肠癌细胞具有细胞毒性。
Mol Oncol. 2021 Dec;15(12):3385-3403. doi: 10.1002/1878-0261.13104. Epub 2021 Oct 21.
9
The Role of NKT Cells in Glioblastoma.自然杀伤 T 细胞在胶质母细胞瘤中的作用。
Cells. 2021 Jun 30;10(7):1641. doi: 10.3390/cells10071641.
10
Invariant natural killer T cells balance B cell immunity.先天自然杀伤 T 细胞平衡 B 细胞免疫。
Immunol Rev. 2021 Jan;299(1):93-107. doi: 10.1111/imr.12938. Epub 2021 Jan 12.
Blood. 2009 Jun 18;113(25):6382-5. doi: 10.1182/blood-2009-01-198564. Epub 2009 Feb 20.
4
Harnessing invariant NKT cells in vaccination strategies.在疫苗接种策略中利用不变自然杀伤T细胞。
Nat Rev Immunol. 2009 Jan;9(1):28-38. doi: 10.1038/nri2451.
5
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.不变自然杀伤T细胞可降低甲型流感病毒诱导的小鼠和人类骨髓来源抑制细胞的免疫抑制活性。
J Clin Invest. 2008 Dec;118(12):4036-48. doi: 10.1172/JCI36264. Epub 2008 Nov 13.
6
Immune therapy for cancer.癌症免疫疗法
Annu Rev Immunol. 2009;27:83-117. doi: 10.1146/annurev.immunol.021908.132544.
7
NKT-cell help to B lymphocytes can occur independently of cognate interaction.自然杀伤T细胞对B淋巴细胞的辅助作用可独立于同源相互作用而发生。
Blood. 2009 Jan 8;113(2):370-6. doi: 10.1182/blood-2008-06-166249. Epub 2008 Oct 2.
8
Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.血管靶向肿瘤坏死因子-α可提高阿霉素对前列腺癌的治疗指数。
Prostate. 2008 Jul 1;68(10):1105-15. doi: 10.1002/pros.20775.
9
Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma.I型自然杀伤T细胞保护(而II型自然杀伤T细胞抑制)宿主对B细胞淋巴瘤的先天性抗肿瘤免疫反应。
Blood. 2008 Jun 15;111(12):5637-45. doi: 10.1182/blood-2007-05-092866. Epub 2008 Apr 16.
10
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.肿瘤相关巨噬细胞在肿瘤进展和免疫监视中的阴阳学说
Immunol Rev. 2008 Apr;222:155-61. doi: 10.1111/j.1600-065X.2008.00607.x.